Artículos del autor

solaci

TAVR vs. the Least Invasive Surgically Implanted Valve

Rapid-deployment surgically implanted valves are designed to make a surgeons’ job faster and easier, compared with conventional...

27/04 | SOLACI / BIOTRONIK Webinar

We invite you to participate in a new SOLACI virtual event open to the entire community. It...

The Future of Prevention? Stenting Vulnerable Fractional FFR Negative Lesions

For many patients, the first symptom of heart disease is acute MI, or even sudden death.  Changes in...

The Best Anticoagulant Agent for AF After TAVR

Direct anticoagulant agents were associated with lower long-term mortality in patients with atrial fibrillation (AF) discharged after...

Silent Stroke During TAVR and Early Cognitive Impairment

Silent stroke is common after transcatheter aortic valve replacement (TAVR). Co-morbidities such as diabetes or chronic renal...

Post MI Betablockers for Good?

Patients receiving optimal medical treatment after MI do not seem to benefit from betablockers in the long...

SOLACI Sessions Changes Authorities

Dr. Gustavo Vignolo (Uruguay) has taken office as SOLACI Sessions Director after the successful administration of Doctor...

SOLACI Research Continues to Consolidate its Investigation Registries | REDCAP SOLACI

The Latin American Society of Interventional Cardiology has decided to hire the REDCap database platform to keep developing...